SynthesisCancer medicine2019

Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta-analysis and systematic review.

Qingliang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.